BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhan D, Wei S, Liu C, Liang B, Ji G, Chen X, Xiong M, Huang Z. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma: Reduced N-cadherin expression. Journal of Gastroenterology and Hepatology 2012;27:173-80. [DOI: 10.1111/j.1440-1746.2011.06847.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Li L, Yu S, Wu Q, Dou N, Li Y, Gao Y. KLF4-Mediated CDH3 Upregulation Suppresses Human Hepatoma Cell Growth and Migration via GSK-3β Signaling. Int J Biol Sci 2019;15:953-61. [PMID: 31182916 DOI: 10.7150/ijbs.30857] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
2 Liu YA, Liang BY, Guan Y, You J, Zhu L, Chen XP, Huang ZY. Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcomes of liver resection in hepatocellular carcinoma. J Surg Res 2015;194:167-76. [PMID: 25438959 DOI: 10.1016/j.jss.2014.09.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rodríguez-perálvarez M, Luong TV, Andreana L, Meyer T, Dhillon AP, Burroughs AK. A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability. Ann Surg Oncol 2013;20:325-39. [DOI: 10.1245/s10434-012-2513-1] [Cited by in Crossref: 257] [Cited by in F6Publishing: 265] [Article Influence: 25.7] [Reference Citation Analysis]
4 Jeong S, Zheng B, Wang H, Xia Q, Chen L. Nervous system and primary liver cancer. Biochim Biophys Acta Rev Cancer 2018;1869:286-92. [PMID: 29660379 DOI: 10.1016/j.bbcan.2018.04.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Becker SF, Langhe R, Huang C, Wedlich D, Kashef J. Giving the right tug for migration: Cadherins in tissue movements. Archives of Biochemistry and Biophysics 2012;524:30-42. [DOI: 10.1016/j.abb.2012.02.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
6 Ma J, Zhao J, Lu J, Wang P, Feng H, Zong Y, Ou B, Zheng M, Lu A. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT. Tumour Biol 2016;37:9077-88. [PMID: 26762412 DOI: 10.1007/s13277-015-4555-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
7 Fan M, Liu Y, Xia F, Wang Z, Huang Y, Li J, Wang Z, Li X. Increased expression of EphA2 and E-N cadherin switch in primary hepatocellular carcinoma. Tumori 2013;99:689-96. [DOI: 10.1177/030089161309900608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
8 Zhuo H, Jiang K, Dong L, Zhu Y, Lü L, Lü Y, Zhang Y, Zhang H, Ye Y, Wang S. Overexpression of N-cadherin is correlated with metastasis and worse survival in colorectal cancer patients. Chin Sci Bull 2013;58:3529-34. [DOI: 10.1007/s11434-013-5813-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ghouraba MH, Masad RJ, Mpingirika EZ, Abdelraheem OM, Zeghlache R, Alserw AM, Amleh A. Role of NELF-B in supporting epithelial-mesenchymal transition and cell proliferation during hepatocellular carcinoma progression. Oncol Lett 2021;22:761. [PMID: 34539865 DOI: 10.3892/ol.2021.13022] [Reference Citation Analysis]
10 Luo Y, Yu T, Zhang Q, Fu Q, Hu Y, Xiang M, Peng H, Zheng T, Lu L, Shi H. Upregulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumours: A meta-analysis. Eur J Clin Invest 2018;48. [PMID: 29405291 DOI: 10.1111/eci.12903] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
11 Gao H, Niu W, He Z, Gao C, Peng C, Niu J. SEC61G plays an oncogenic role in hepatocellular carcinoma cells. Cell Cycle 2020;19:3348-61. [PMID: 33171060 DOI: 10.1080/15384101.2020.1843816] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Iguchi T, Shirabe K, Aishima S, Wang H, Fujita N, Ninomiya M, Yamashita Y, Ikegami T, Uchiyama H, Yoshizumi T. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation. Transplantation. 2015;99:1236-1242. [PMID: 25427164 DOI: 10.1097/tp.0000000000000489] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
13 Chen Q, Lu X, Xie J, Ma N, Xu W, Zhang Z, Huang X, Liu H, Hou J, Zhang X, Zhu W. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma. Front Oncol 2022;12:813275. [DOI: 10.3389/fonc.2022.813275] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Takamura H, Nakanuma S, Hayashi H, Tajima H, Kakinoki K, Sakai S, Makino I, Nakagawara H, Miyashita T, Okamoto K, Nakamura K, Oyama K, Inokuchi M, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Ohnishi I, Kayahara M, Tani T, Arai K, Yamashita T, Yamashita T, Kitamura H, Ikeda H, Kaneko S, Nakanuma Y, Matsui O, Ohta T. Evaluation of eligibility criteria in living donor liver transplantation for hepatocellular carcinoma by α-SMA-positive cancer-associated fibroblasts. Oncol Rep 2013;30:1561-74. [PMID: 23863893 DOI: 10.3892/or.2013.2616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
15 Zhao J, Li P, Feng H, Wang P, Zong Y, Ma J, Zhang Z, Chen X, Zheng M, Zhu Z, Lu A. Cadherin-12 contributes to tumorigenicity in colorectal cancer by promoting migration, invasion, adhersion and angiogenesis. J Transl Med 2013;11:288. [PMID: 24237488 DOI: 10.1186/1479-5876-11-288] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
16 Zhou SJ, Liu FY, Zhang AH, Liang HF, Wang Y, Ma R, Jiang YH, Sun NF. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Br J Cancer 2017;117:233-44. [PMID: 28588321 DOI: 10.1038/bjc.2017.164] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]